CapsoVision (CV) Accounts Payables (2024 - 2026)
CapsoVision (CV) posted Accounts Payables of $1.1 million for Q4 2025, down 15.02% sequentially from $1.3 million in Q3 2025, and up 52.6% YoY from $749000.0 in Q4 2024.
CapsoVision (CV) Accounts Payables (2024 - 2026) Analysis & Trends
CapsoVision has reported Accounts Payables for 2 years, with the latest figure at $1.1 million in Q4 2025.
- Quarterly Accounts Payables rose 52.6% year-over-year to $1.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.1 million (up 52.6% YoY) and the FY2025 annual result came in at $1.1 million, up 52.6% from the prior year.
- Accounts Payables slipped to $1.1 million in Q4 2025 per CV's latest filing, from $1.3 million in the prior quarter.
- Over five years, Accounts Payables peaked at $1.3 million in Q3 2025 and troughed at $749000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.34 Bn | 196.74 Bn | 7.27 Bn | 4.79 Bn |
| 2 | Stryker | 127.25 Bn | 123.78 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 119.13 Bn | 109.91 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 74.49 Bn | 73.95 Bn | 3.85 Bn | 1.23 Bn |
| 5 | Edwards Lifesciences | 51.80 Bn | 47.54 Bn | 1.35 Bn | 210.50 Mn |
| 6 | Dexcom | 35.04 Bn | 33.09 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.84 Bn | 31.73 Bn | 2.18 Bn | 3.23 Bn |
| 8 | Koninklijke Philips | 26.25 Bn | 22.93 Bn | 4.55 Bn | 2.42 Bn |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 344.10 Mn |
| 10 | CapsoVision | 301.62 Mn | 292.55 Mn | 1.87 Mn | 475,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 475,000.00 |
| Dec 31, 2025 | 1.14 Mn |
| Sep 30, 2025 | 1.35 Mn |
| Jun 30, 2025 | 1.16 Mn |
| Dec 31, 2024 | 749,000.00 |